PPARGC1A and prostate carcinoma: In a study on prostate cancer, androgens signaling via AMPK led to increased PGC1α mitobiogenesis and OXPHOS but also glycolysis; analyses of mouse xenografts and patient samples suggested that AMPK/PGC1α correlated with cancer growth [32].